Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Patient Reported Symptoms and Tryptase Levels in WHO-Defined Systemic Mastocytosis (SM) Versus Mast Cell Activation Syndrome (MCAS) Versus Neither

Darci Zblewski, CNP, Ramy A. Abdelrahman, MBBCh, Dong Chen, MD PhD, Joseph H. Butterfield, MD, Ayalew Tefferi, MD, Animesh Pardanani, MBBS, PhD

Blood (2014) 124 (21): 3204.

https://doi.org/10.1182/blood.V124.21.3204.3204

Published: 2014

Journal Articles

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

Ken-Hong Lim, Ayalew Tefferi, Terra L. Lasho, Christy Finke, Mrinal Patnaik, Joseph H. Butterfield, Rebecca F. McClure, Chin-Yang Li, Animesh Pardanani

Blood (2009) 113 (23): 5727–5736.

https://doi.org/10.1182/blood-2009-02-205237

Published: 2009

Journal Articles

TG101348, An Orally Bioavailable JAK2-Selective Inhibitor, Potently Inhibits KITD816V and FIP1L1-PDGFRA in Vitro

Jaya Kittur, MD, Terra L Lasho, MT(ASCP), Joseph H Butterfield, MD, Jolene Shorr, Ayalew Tefferi, MD, Animesh D. Pardanani, MBBS, PhD

Blood (2008) 112 (11): 2807.

https://doi.org/10.1182/blood.V112.11.2807.2807

Published: 2008

Journal Articles

Cytoreductive Therapy in Systemic Mastocytosis: Outcome Analysis and Response Prediction in 134 Consecutive Patients.

Ken-Hong Lim, Animesh D. Pardanani, MBBS, PhD, Joseph H Butterfield, MD, Chin Yang Li, MD, Ayalew Tefferi, MD

Blood (2008) 112 (11): 1759.

https://doi.org/10.1182/blood.V112.11.1759.1759

Published: 2008

Journal Articles

Low Incidence of FIP1L1-PDGFRA in Eosinophilic Patients and Long-Term Experience with Imatinib Therapy.

Animesh D. Pardanani, MD, PhD, Rhett P. Ketterling, MD, Chin-Yang Li, MD, Alexandra P. Wolanskyj, MD, Michelle A. Elliott, MD, John K. Camoriano, MD, Joseph H. Butterfield, MD, Gordon W. Dewald, PhD, Ayalew Tefferi, MD

Blood (2005) 106 (11): 2590.

https://doi.org/10.1182/blood.V106.11.2590.2590

Published: 2005

Journal Articles

Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli

Hitoshi Kobayashi, Gerald J. Gleich, Joseph H. Butterfield, Hirohito Kita

Blood (2002) 99 (6): 2214–2220.

https://doi.org/10.1182/blood.V99.6.2214

Published: 2002

Journal Articles

The c- KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations

Yongsheng Ma, Shan Zeng, Dean D. Metcalfe, Cem Akin, Sasa Dimitrijevic, Joseph H. Butterfield, Gerald McMahon, B. Jack Longley

Blood (2002) 99 (5): 1741–1744.

https://doi.org/10.1182/blood.V99.5.1741

Published: 2002

Journal Articles

Expression of Functional TrkA Receptor Tyrosine Kinase in the HMC-1 Human Mast Cell Line and in Human Mast Cells

See-Ying Tam, Mindy Tsai, Masao Yamaguchi, Koji Yano, Joseph H. Butterfield, Stephen J. Galli

Blood (1997) 90 (5): 1807–1820.

https://doi.org/10.1182/blood.V90.5.1807

Published: 1997

NARROW

Patient Reported Symptoms and Tryptase Levels in WHO-Defined Systemic Mastocytosis (SM) Versus Mast Cell Activation Syndrome (MCAS) Versus Neither

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

TG101348, An Orally Bioavailable JAK2-Selective Inhibitor, Potently Inhibits KITD816V and FIP1L1-PDGFRA in Vitro

Cytoreductive Therapy in Systemic Mastocytosis: Outcome Analysis and Response Prediction in 134 Consecutive Patients.

Low Incidence of FIP1L1-PDGFRA in Eosinophilic Patients and Long-Term Experience with Imatinib Therapy.

Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli

The c- KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations

Expression of Functional TrkA Receptor Tyrosine Kinase in the HMC-1 Human Mast Cell Line and in Human Mast Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only